Not whether a public quote exists, but how far down the instrument is identified

TL;DR

"Does a public quote exist" is a yes-or-no question. What this data actually carries is a depth — an instrument can be identified or unidentified at three separate levels.

• Of the 100 instruments, 8 carry a type recorded as unclassified, meaning the listing status of the underlying company could not be established at ingest. This group holds 5 of them (the other 3 are CBRSB, CYPHB and USDEB).
• One level further down: the underlying names of BOTB and SECZB were read back out of the token names, not supplied upstream. Six instruments on the book have a name obtained that way, and only 4 of those are also unclassified by type — BOTB, SECZB, CYPHB, USDEB. This group holds 2.
• The price consequence, controlled for window: within their own listing batches, four of the five are the widest instrument of that batch, and the windows of AGPUB (39 days), SHAZB (32) and SECZB (24) are all under 40 days. SPCXB in the first article took 142 days to reach 2.168x; SHAZB reached 2.688x in 32.
• The counter-example is QNTB. It is the longest-listed member at 103 days and 2.249x wide, yet it ranks only 7th of the ten instruments listed with it — four leveraged ETFs, one plain common stock (AXTIB at 2.658x) and CRWVB (2.274x) are all wider.
• This property predicts neither size nor attention. SPCXB has no public quote either, carries a $173.96M market cap and is the largest instrument on the book; these five total $7.17M, 1/24th of SPCXB alone. The smallest instrument on the whole book is this group's BOTB at $415.5K.
• The −58.17% 30-day decline on SHAZB is the third worst on the book and the worst of any unlevered instrument — only INTWB and SNXXB, both 2x leveraged ETFs, did worse.
• This snapshot cannot produce a premium. It carries no underlying reference price and no dividend-reinvestment multiplier, so this piece publishes no premium or discount figure at all — not an omission, an impossibility.

1. What these five are

bStocks is Binance's in-house tokenized-equity issuer (BTech Holdings Limited, ADGM / FSRA listed certificates, BNB Chain only, traded on Binance only). CoinMarketCap reports 105 instruments; the snapshot behind this piece holds 100 of them, timestamped 2026-10-31T06:06:52Z.

What these five share is not an industry. It is that none of them has a public quote that can be independently cited.

Together they hold $7.17M of the book's $1,318.38M — 0.5% — and $7.67M of its $873.46M of volume, 0.9%. The $415.5K on BOTB is the smallest market cap of all 100 instruments.

The first article already handled one instance of this property: SPCXB, the largest instrument on the book, whose underlying SpaceX is private, so no exchange price exists to measure it against. This piece does not repeat that observation. It goes one layer down, because "no public quote" is not a switch in this data.

2. No public anchor is not a switch, it is a depth

This data records three things about each instrument: the type of the underlying (common stock / ADR / ETF / pre-IPO / unclassified), the symbol of the underlying, and the name of the underlying — plus whether that name came from upstream or was inferred.

Those three can fail separately, so "unidentified" has levels:

The first level is the shallowest, and it misleads. Of the 17 with an empty symbol, 5 are the 2x leveraged tokens from the second article — their underlyings are ETFs rather than stocks, so no stock symbol is correct; another is SKHYB, whose underlying SK Hynix is listed in Korea with no US ticker; another is SPCXB, whose underlying is private. In the other direction, BNCB and FWDIB have their type recorded explicitly as common stock and still carry an empty symbol. So "no symbol" neither implies nor denies an anchor.

The second level is what defines this group. Type unclassified has a specific meaning: at ingest it could be established neither that the underlying is a US common stock nor that it is private, so the field was left blank rather than guessed. Eight on the book, five here, the other three being CBRSB (in the neocloud group), CYPHB and USDEB.

The third level is BOTB and SECZB. Their underlying names were read back out of the token names. Six instruments on the book have a name obtained that way, but for two of the other four the inference is verifiable: BRKBB resolves to Berkshire Hathaway, with the symbol BRK.B filled in by hand; SKUUB resolves to a GraniteShares 2x SK Hynix product. Those two inferences landed on something that demonstrably exists.

The remaining 4 are both unclassified by type and named by inference — BOTB, SECZB, CYPHB, USDEB, and this group holds 2 of them. For those two rows, everything this data provides is a token symbol, a name derived from that symbol, and a price series.

That is this piece advancing on the first one. SPCXB has no public quote, but its type is settled (pre-IPO), its name came from upstream, and its underlying is a company everyone knows. "No public quote" and "not even established what the underlying is" are not the same thing, and this data records them separately.

One detail worth noting in passing: the underlying of SECZB is Securitize, a company in the business of tokenizing assets. A tokenized certificate whose underlying is a tokenization company, and whose name was inferred from the token symbol. That is an observation, not a comment.

3. Controlled for window: they are the widest in four batches

Range width = highest price since listing ÷ lowest.

The windows here run from 12 to 103 days, an 8.6-fold spread, so comparing the rows of that table directly is meaningless.

The comparison that works is each instrument against those listed on the same day — identical windows:

In four of five batches the widest instrument is a member of this group.

The force of that comparison is that it removes the window: SHAZB and FWDIB listed the same day (2026-09-29) with identical 32-day windows, at 2.688x against 1.419x — 89% apart. SECZB and USDEB listed the same day (2026-10-07) with identical 24-day windows, at 2.092x against 1.711x.

And the short window is working against them, not for them. The first article established that a longer listing gives more chances to print an extreme, so a narrow range on a newly listed instrument carries no information — the narrowest on the book, BRKBB at 1.031x, has been listed only 12 days. Against that premise, SHAZB covering 2.688x in 32 days and SECZB 2.092x in 24 is more notable, not less. For reference, the 2.168x on SPCXB took 142 days.

The 2.688x on SHAZB is the eighth-widest of all 100 on a 32-day window — and five of the seven above it are leveraged or inverse ETFs.

The 30-day declines point the same way:

• The −58.17% on SHAZB is the third worst on the book and the worst of any unlevered instrument. Only INTWB (−78.03%) and SNXXB (−61.18%) did worse, both 2x leveraged ETFs.
• SECZB −38.92%, AGPUB −30.70% and QNTB −30.51% are all worse than the book median of −16.71%.
• BOTB at −11.58% looks better, but it has been listed 12 days — that figure is its entire history and cannot be compared with anyone else's 30 days. Its 24-hour change of −12.21% is the fourth worst on the book, behind INTWB −22.62%, SNXXB −21.74% and RDDTB −12.81%.

In-range positions agree: SHAZB sits 3.6% up its own range, SECZB 2.9% and QNTB 4.2% — all three pinned to the bottom, while AGPUB at 10.7% and BOTB at 14.6% are the only two of the five any distance off it.

4. The counter-example: QNTB, and two same-property pairs

The table in section 3 invites the reading "no public anchor, therefore widest." It fails in two places.

The first is QNTB, and it happens to be the one with the longest window. Ten instruments listed on 2026-07-20:

QNTB ranks 7th. Four leveraged ETFs being wider is mechanical, but AXTIB and CRWVB are two common stocks with public quotes that can be arbitraged at any time, over the identical 103-day window, and at 2.658x and 2.274x both beat it.

And this is the only member of the group with a window past 100 days. Put those two facts together and the conclusion in section 3 shrinks to this: over short windows of 12 to 39 days, these unidentified instruments are the widest in their own batch; stretch the window to 103 days and ordinary common stocks catch up. That is an observation about short windows, not a law about pricing anchors.

The second place is same-property pairs. Two listing batches contain two unclassified instruments each, which is the cleanest control available — same day, same property:

Listed the same day, both unclassified, and the widths can differ by 6% or by 22%. So the property does not pin a width value — at most it is a tendency. CYPHB and USDEB belong to a different group, not this one, but they share exactly the same identification depth as members here (type unclassified, name inferred).

5. The property predicts neither size nor attention

The error most easily carried along is "instruments with no public anchor are unwanted." This snapshot refutes it from both ends.

Against SPCXB first:

One instrument, SPCXB, carries 24.3 times the combined market cap of this group, and it shares the no-public-quote property with them. So size is not decided by the property — the size of SPCXB comes from the name SpaceX, not from its pricing structure.

Then turnover:

This group turns over 1.62 times as fast as the other 95. SHAZB at 2.726x is the eighth-highest on the book, QNTB at 2.675x the eleventh.

But the caliber warning has to come immediately. Turnover = 24h volume ÷ market cap, and a small denominator inflates the ratio mechanically. SHAZB carries a $530.9K market cap and QNTB $726.9K, against a book median of $2.39M. Their absolute volumes are $1.45M and $1.94M, ranking 69th and 56th on the book. So this group is not actively traded; its float is thin.

Taken together, the property predicts neither size (SPCXB is 1st, BOTB is 100th) nor attention. The only thing it predicts is what section 3 found: over a short window, the price covers more ground.

6. Structure: all five share one wrapper

• The wrapper is a tracker certificate, not equity. The issuing entity is BTech Holdings Limited, ADGM / FSRA listed certificates.
• No voting rights.
• Dividends are passed through: a 30% US withholding deduction first, then reinvestment through a multiplier (see section 8).
• Reserves are covered by attestation, not an on-chain proof of reserve. Among comparable issuers xStocks uses Chainlink proof of reserve, which updates daily or on a 10% move in reserves and can be checked on-chain. An attestation cannot.
• Redemption requires KYC, with a $5 minimum.
• US persons are blocked.
• One chain. BNB Chain only, BSC deposits only, so a wrong-network transfer loses the asset.

This is a description of structure, not an allegation. But for this group it produces one combination that cannot be sidestepped: reserves are backed by an attestation, while this data has not established in what form the underlying company trades — and for BOTB and SECZB, even the name was inferred from the token symbol. The attestation is the issuer's and the identification fields are the ingest step, so the two do not contradict each other; but for a reader, these five rows are the thinnest tier of verifiability on the book. The certificates themselves may be entirely in order — this data cannot be used to judge that. It can only state what it does not know.

7. The snapshot was taken on a Saturday

The timestamp 2026-10-31T06:06:52Z is a Saturday morning UTC. The US cash market closed Friday at 20:00 UTC and does not open again until Monday.

The same issuer has already been measured on this point once: one stock, four books laid the four tokenized versions of AAPL side by side on a Saturday and concluded that a quote outside trading hours is a market maker opinion, not a market price.

For this group, whether that even applies is itself uncertain. In the other groups all underlyings are US-listed, so "the US market is closed" holds unambiguously. Here the listing status could not be established at ingest — if an underlying really is private, the close adds no condition because the reference price never existed; if it is listed somewhere, this data has not recorded that venue's hours either.

The conclusion is the same under both readings but for different reasons: for the two-plus days from here until Monday, these token prices are the only prices these names have — and for these five, quite possibly at any hour.

8. What this method cannot calculate

First, no premium or discount. The snapshot carries only the token price and no reference price for the underlying. For this group that holds harder than for the others: it has not even been established whether a public price for the underlying exists. And the bStocks dividend mechanism takes a 30% US withholding deduction before reinvesting through a multiplier, so without the current multiplier the token unit price and any underlying share price are not comparable quantities. This piece publishes no premium figure.

Second, no shares per token. The snapshot has no conversion ratio. The 23,273 SHAZB tokens in circulation cannot be converted into any number of shares without it.

Third, nothing about the underlying follows from "type unclassified." The field means "could not be established at ingest." It does not mean private and does not mean nonexistent. This piece treats it throughout only as "this data does not know," never as a judgement about the company.

Fourth, the range-width windows are not equal length, and in this group that is severe. This group runs 12 / 24 / 32 / 39 / 103 days, an 8.6-fold spread. Book-wide comparisons use only the 46 instruments listed 100 days or more — only QNTB is among those 46, at 36th — which is why all of section 3 uses same-day batches as window-controlled comparisons rather than book-wide ranks.

Fifth, market cap is the CMC definition: price × circulating supply. The book total of $1,318.38M here is these 100 rows added up, while the /stocks page on this site shows $914M of on-chain value for the bStocks row — two figures from different sources at different moments, and they will not reconcile. This piece uses the former throughout and timestamps it everywhere.

Sixth, 100 of 105. CMC reports 105 instruments, the snapshot holds 100, and the missing 5 are in none of these statistics. That matters more here: if any of the missing 5 is also unclassified, both the 8 and the 4 in section 2 grow.

Seventh, turnover = 24h volume ÷ market cap. Section 5 already shows the high turnover here comes first from a small denominator. It cannot be read as this group having better liquidity.

Conclusion. The first article concluded that a looser anchor means a wider range, and its loosest example, SPCXB, still had a settled type, a name supplied upstream, and an underlying company everyone knows. These five go one layer down: their listing status could not be established at ingest (8 on the book, 5 here), and the names of BOTB and SECZB were read back out of the token symbols (only 4 instruments on the book satisfy both conditions, and 2 of them are here).

The price consequence is clearest controlled for window: in four of five listing batches the widest instrument is a member of this group, with SHAZB covering 2.688x in 32 days — the eighth-widest range on the book — and SECZB 2.092x in 24, against the 142 days SPCXB took to reach 2.168x. The −58.17% on SHAZB over 30 days is the worst of any unlevered instrument on the book.

But it holds only over short windows. QNTB, the only member listed a full 103 days, ranks 7th of ten in its batch, beaten by two common stocks with public quotes; and in the two batches that each contain two unclassified instruments, the widths differ by 6% and 22%. The property does not pin a number.

What travels is an order of questioning. Do not stop at "does this token have a public quote to measure against." Ask two more: has its type been established, and did its underlying name come from upstream or get inferred from the token symbol? For these five rows the answer to the first is "not established," and for two of them the answer to the second is "inferred."

Data from CoinMarketCap, timestamped 2026-10-31T06:06:52Z, covering 100 of the 105 instruments bStocks reports. Instrument detail and quotes at /stocks/bstocks. Research notes, not investment advice. DYOR.